Sandiṭṭhiko

22.4K posts

Sandiṭṭhiko banner
Sandiṭṭhiko

Sandiṭṭhiko

@Sandiithiko

Investor of @IBRX for curing cancers

Katılım Kasım 2024
266 Takip Edilen530 Takipçiler
Sabitlenmiş Tweet
Sandiṭṭhiko
Sandiṭṭhiko@Sandiithiko·
The most Important Science of the decades is here and curing diseases and enhances longevity. Introducing CAR-NK Cells expressing PD-L1. The most Important and Useful Cells in our bodies to fight ALL types of Cancers and Infections. BioShield
Dr. Pat Soon-Shiong@DrPatrick

2025 was the unveiling of the Bioshield Platform - Anktiva as foundation for killer cells. Now for 2026 unveil. Next element to Bioshield Platform - engineered NK cells to TARGET cancer. The CAR-NK in Phase 2 trials infused w/ Anktiva pubmed.ncbi.nlm.nih.gov/32439799/ See you at JPM26

English
162
5
46
11.8K
Sandiṭṭhiko
Sandiṭṭhiko@Sandiithiko·
@ScholarshipfPhd True. A staining protocol of half a page can be expanded into a 15-page article and published. what a cute joke of paper makers at the universities.
English
0
0
0
93
Sandiṭṭhiko retweetledi
Massimo
Massimo@Rainmaker1973·
This are heart cells. Beating. Using stem cells, scientists can grow cardiac tissue in a petri dish. The cells self-organize to form microchambers, which begin to beat like a full-sized heart. [📹 Jessica Gluck]
English
26
89
458
43K
Sandiṭṭhiko
Sandiṭṭhiko@Sandiithiko·
@khnh80044 Nice. Stop statin drug, eat avocado and/or coconut meat or coconut oil cold press. Then take Ivermectin, artemisinin + Berberine to revert alzheimer and dementia or brain fog...
English
0
0
0
26
Love Music
Love Music@khnh80044·
Father with Alzheimer's recognizes his daughter for a moment 🥹❤️
English
64
386
9.7K
345.7K
Anton
Anton@seahorse_anton·
🙏 Sis! There is lot of info. We cannot learn all. May be I will write a detailed post later. Some info... 1) Macro (The Climate): Track the 10Y-2Y yield curve (economic health), CPI (inflation), and the DXY (US Dollar strength). These dictate the "price of money. This one also pretty tough for me to understand. Can drain u sometimes. Better to pick one first. My pick is rotation! 2) Rotation (The Flow): Capital shifts based on cycles. Cyclicals (Tech/Financials) thrive in growth; Defensives (Staples/Healthcare) lead in volatility; Energy/Materials hedge against sticky inflation. Every week, I also update the sector rotation analysis. I focus here now! May b in the future also! 3) Use FRED (fred.stlouisfed.org) for macro data and Koyfin or StockCharts to compare sector ETFs against the S&P 500 to see where institutions are moving cash. I rarely use the website. Also understanding all Macro is not necessary. Pretty much I look at the Macro at surface level and focus more on TA, fundamentals, stock research and sector rotation. Should write more educational posts.
English
1
1
2
106
Anton
Anton@seahorse_anton·
Most people compete for attention. Few compete for understanding. Learn valuable skills. Think independently. Stay patient. The market transfers wealth from impulse to discipline. Build enough substance, and opportunities will find you. — Anton
English
2
1
7
227
Oshin
Oshin@Oshin76·
@Sandiithiko @TrueValueHunter Haha, I don’t drink which leaves me with more money to invest in this and honestly, it wouldn’t hurt to skip a meal or two either.
English
1
0
1
9
The Value Hunter
The Value Hunter@TrueValueHunter·
The math behind the IBRX squeeze is screaming. 🧵 The float is ~290M shares, yet ~132M are held short. That’s nearly 45% of the float tied up in a losing battle. The shorts are trapped, and the setup is becoming explosive. 📈 $IBRX
English
3
7
52
2.9K
Anton
Anton@seahorse_anton·
bitcoin:native most likely to drop. $ETH the dance between the 1550 to 2300 will continue. But it gives strange signals! If I enter with DCA approach, I would prefer solana:So11111111111111111111111111111111111111112 (the % profit in short term is higher - but with strict SL at 55 ). I don’t even care about any-other coins.
English
1
0
4
289
Sandiṭṭhiko
Sandiṭṭhiko@Sandiithiko·
It is all about the story to tell to guide the money flow. Where is the next stream for money to flow in....Biotech? New Cancer Treament without Chemo? Longevity? Super-Immunity? All paths lead to $IBRX. - OpenAI is making no money. - $IBRX making $$$$$$$$$$$$$$$$$$$$$$$$$
Sandiṭṭhiko tweet mediaSandiṭṭhiko tweet mediaSandiṭṭhiko tweet mediaSandiṭṭhiko tweet media
Sandiṭṭhiko@Sandiithiko

- Can't have enough shares $IBRX before Q2 Earning!!! - IL15 + Engineered NK Cells + Nantibodies is the full protection our bodies need. - No cancer, No infections, No malfunctional cells in our bodies.

English
0
0
3
129
AbSURDIDIOT
AbSURDIDIOT@subaru_wrx0219·
$ORCL If you are not buying right here you hate money
AbSURDIDIOT tweet media
English
1
0
0
144
Sandiṭṭhiko
Sandiṭṭhiko@Sandiithiko·
@seahorse_anton Thanks! I can relax a bit now. I hope they rotate to keep the market not down to attract money, because if bubble burst, foreigners will cash out money making USD weak. AI keeps borrowing $ to buy their stocks and centers and get deduction. They burn someone else money, not their
English
0
0
1
19
Anton
Anton@seahorse_anton·
@Sandiithiko No fear. I rotate. Still Biopharma major holding for me. AI bubble - Company specific. Semis (big FCF) vs hyper scalers ( debts increasing now ). Sure for second half FCF and CapEX is going to determine . Hope they don’t dilute stocks to fund their AI growth. Will update
English
1
0
1
27
Anton
Anton@seahorse_anton·
$ORCL testing the support soon at 134. If the downward journey continues, 104.18 (read below). Some oscillation expected at 125. 52 week low- 200 week low all at the same time. I wrote about the CapEX - debt trap since Jan.
Anton@seahorse_anton

WEEKLY QUANT REPORT: ENTERPRISE SOFTWARE & AI REGIME $ORCL $PLTR REGIME STATE: SYSTEMIC POLARIZATION (ORCL ACCELERATING BREAKDOWN VS. PLTR ACCUMULATION COMPRESSION) 1. INDIVIDUAL ASSET REGIME CORES PLTR (Palantir Technologies) | SIGNAL: NEUTRAL ⚖️ Current Price: $126.79 | Alpha Score: -0.054 | Model Accuracy: 76.5% Trade Parameters: Target: $152.97 | Invalidation Floor: $100.61 Outcome Profile: P(Profit): 12.9% | P(Neutral): 78.7% | P(Loss): 8.3% | Risk/Reward: 1.55x Quant Footprint: PLTR has completely flattened its near-term directional velocity, pulling back into a massive 78.7% Neutral Probability stasis field. While the macro posture shows temporary downtrend consolidation under the cloud, the internal structural metrics have thoroughly snuffed out tail risk, compressing the absolute loss probability to a minor 8.3%. Perfect feature stability (Range_width Mean: 0.1699, ADX Mean: 0.1380, CMF Mean: 0.0860, CV < 0.10) confirms that large institutional scale blocks are running a strict passive limit-order grid beneath the market. This creates deep structural insulation right around the $120 layer, transforming this range into an accumulation zone while the asset builds energy to challenge the upper $152.97 target boundary. ORCL (Oracle Corporation) | SIGNAL: STRONG BEARISH 🚨 Current Price: $140.64 | Alpha Score: -0.419 | Model Accuracy: 73.1% Trade Parameters: Short Target: $104.18 | Cover Stop: $177.10 Outcome Profile: P(Short Target): 49.2% | P(Neutral): 43.5% | P(Loss/Upside): 7.3% | Risk/Reward:0.15x Quant Footprint: ORCL is experiencing an accelerating structural breakdown, triggering a high-conviction Strong Bearish allocation signal. The predictive matrix maps out a highly toxic, asymmetrical distribution profile, where the probability of a major downward slide dominating at 49.2% completely eclipses a negligible 7.3% upside potential. Flawlessly consistent features (Zscore_Vol Mean: 0.1391, CMF Mean: 0.1203, RSI Mean: 0.1008) verify that institutional money centers are actively and linearly liquidating exposure on any intra-week relief attempts. The asset has severed its baseline moving average structures, opening a clean downside path toward the $104.18 macro target. 2. QUANT DATA COMPRESSION LENS (EASY-COPY LIST) PLTR (Palantir Technologies) Metrics: Spot $126.79 | ML Score -0.054 | Acc 76.5% Odds: P(Profit) 12.9% | P(Loss) 8.3% | P(Neutral) 78.7% Boundary: Target $152.97 | Stop $100.61 | R/R 1.55x Stance: Neutral Volatility Squeeze / Downside Floor Secure ⚖️ ORCL (Oracle Corporation) Metrics: Spot $140.64 | ML Score -0.419 | Acc 73.1% Odds: P(Short Target) 49.2% | P(Loss/Upside) 7.3% | P(Neutral) 43.5% Boundary: Target $104.18 | Stop $177.10 | R/R 0.15x Stance: Strong Bearish / Accelerating Institutional Liquidation 🚨 3. INTEGRATED SECTOR VERDICT The enterprise big data and cloud architecture complex has fractured into starkly decoupled execution profiles. Blindly buying software indices here exposes portfolios to significant capital erosion due to the heavy institutional selling concentrated in legacy names. PLTR remains an exceptional Asymmetric Accumulation Vehicle. While the 78.7% neutral wall ensures it acts as temporary "dead money" for short-term momentum traders, the complete collapse of downside failure risk (8.3%) allows systematic desks to comfortably build core equity exposure at current prices ahead of the next major expansion leg. ORCL represents a mandatory Avoid or Short Position. Pinned under an abysmal 0.15x probability-weighted R/R profile and backed by high feature liquidation metrics, any localized relief rallies back toward the weekly Kijun-sen boundaries should be aggressively sold to target the structural liquidity pocket down at $104.18.

English
1
1
4
1.3K
Anton
Anton@seahorse_anton·
Nah, Oracle isn’t collapsing. Too big to fail & too much revenue. But the leverage is crazy: total debt went from ~$85B to $167.4B after borrowing $43B in FY26 to buy chips & build data centers. The real test: Can they convert that massive subscription backlog into actual Free Cash Flow? If AI clients survive, this is a masterstroke. If they go bust, it's a cautionary tale of hype. Unlikely they fail, but keeping eyes on the balance sheet. One real test for this space If Chinese models commoditize raw intelligence and bring prices down to next to nothing - which we are already seeing in 2026 with companies like DeepSeek and Z.ai undercutting US rivals
English
2
0
2
36
Sandiṭṭhiko
Sandiṭṭhiko@Sandiithiko·
We are in half month of July when $IBRX Q2 earning can come out anytime. Treating myself some beer while lossing money of price down. Its OK, @DrPatrick never sell. Just keep some money to eat. Don't all in anything as the AI bubble can burst anytime. 2000 and 2008 can repeat.
Sandiṭṭhiko tweet media
Sandiṭṭhiko@Sandiithiko

When people understand how powerful is this photo of @DrPatrick Founder - CEO of $IBRX shaking hands with Trump and King of Saudi, they will fight to buy shares. Now we amd whales just accumulate more shares thanks to the evil shorts keep selling to us at super cheap price :)

English
0
0
2
155